Zus Health, a healthtech platform for connected healthcare, raised US$33 million in Series B funding. Drive Capital led the round. Sanofi Ventures, HealthX Ventures, Alumni Ventures, and existing investors also participated.
Funding so far
The Series B brings Zus Health's total capital raised to more than US$100 million. Existing investors Andreessen Horowitz, F-Prime, Maverick Ventures, and JAZZ Venture Partners joined the round. The company will use the capital to invest in its patient record platform, data network, and AI-powered clinical workflows.
Company context
Zus Health was founded in 2021 by Jonathan Bush, co-founder and former CEO of athenahealth. The company serves value-based care organizations, digital health companies, provider organizations, and diagnostics and precision medicine innovators. In August 2026 its network supported more than 110 million networked transactions.
What the platform does
The Zus Aggregated Profile brings fragmented clinical information into one longitudinal patient record. The platform connects data across EHR networks, pharmacies, labs, and care event notifications. Its AI-powered Generated Patient Summaries help care teams use fragmented records more efficiently.
Zus plans to advance its AI-powered clinical intelligence and platform capabilities. It also plans to broaden connectivity and improve record freshness across its national data network. The company will expand Zus-powered workflows for value-based care, specialty care, and other high-value use cases.